The world of Kedrion Biopharma at a glance:
discover the latest
up-to-date news.

Kedrion grows in North America as it completes acquisition of Prometic
Launch is planned for the first ever FDA-approved treatment for patients suffering from Congenital Plasminogen Deficiency
Read all
Kedrion Biopharma expands its commitment in Turkey
Expansion plans revealed at Embassy reception in Ankara on October 14
Read all
4ID – Kedrion proud to support new App for patients with Immunodeficiencies
Our company restates its long-standing and consistent collaboration with IPOPI
Read all